drugset / Trial / NCT00833859
Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out if a program of intensive chemotherapy with gemcitabine, docetaxel and capecitabine followed by an advanced form of focused radiation aimed at the patient's tumor followed by more chemotherapy can increase the chances that the patient's pancreatic tumor can be removed completely.
Timeline
- Start
- 2009-03
- Primary completion
- 2010-03
- Completion
- 2010-03
Outcome
Outcome not reported
Stopped (Enrollment): “Abandoned - Lack of funding after only 2 patients enrolled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 750 mg/m2 | Oral |
| Subject | Docetaxel | Small molecule | 30 mg/m2 | Intravenous |
| Subject | Gemcitabine | Small molecule | 750 mg/m2 | Intravenous |